Clinical Trial Update: Efficacy and Safety Study of TAS5315 Compared With Placebo in Participants With Rheumatoid Arthritis. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing efficacy and safety of TAS5315 versus placebo in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• TAS5315 (TAS5315)

Snippet

Sponsor: Taiho Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED